With regard to the clinical application of the gene therapeutic approaches, a tight control of both the spatial and temporal expression of the therapeutic transgene is required, and information concerning gene expression is necessary for therapy planning, and follow up studies in treated tumors and also for prognosis. Recent progress in molecular imaging (MI) techniques enables one to directly or indirectly monitor and record the spatiotemporal distribution of molecular or cellular processes for biochemical, biological, diagnostic, or therapeutic applications (Table 4.2). Based on the application of specific radioactive probes or contrast agents, either direct or indirect evaluation of gene expression is allowed. Direct evaluation is possible with, for example, ligands that directly bind to a specific target (e.g., receptor). Indirect evaluation may be achieved by using specific substrate probes for a target enzyme. By employing reporter genes for molecular imaging of gene expression in gene therapy, direct visualization may be achieved by optical detection of the respective gene product (e.g., green fluorescent protein). Indirect visualization is possible as a result of accumulation of an image probe because of enzymatic action or transporter function of the reporter gene product (e.g., iodine accumulation due to the action of the Na(+)/I(?) symporter). The reporter gene may not have a therapeutic role itself but by coupling it to a therapeutic gene, expression of the reporter gene reports on the expression of the therapeutic gene.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
REFERENCES
Adachi, Y., Tamiya, T., Ichikawa, T., Terada, K., Ono, Y., Matsumoto, K., Furuta, T., Hamada, H., and Ohmoto, T. 2000. Experimental gene therapy for brain tumors using adenovirus-mediated transfer of cytosine deaminase gene and uracil phosphoribosyltransferase gene with 5-fluorocytosine. Hum. Gene Ther. 11: 77–89
Alauddin, M.M., and Conti, P.S. 1998. Synthesis and preliminary evaluation of 9-(4-[18F]-fluoro-3-hydroxymethylbutyl)guanine ([18F]FHBG): a new potential imaging agent for viral infection and gene therapy using PET. Nucl. Med. Biol. 25: 175–180
Alauddin, M.M., Shahinian, A., Kundu, R.K., Gordon, E.M., and Conti, P.S. 1999. Evaluation of 9-[(3-18F-fluoro-1-hydroxy-2-propoxy)methyl]guanine ([18F]-FHPG) in vitro and in vivo as a probe for PET imaging of gene incorporation and expression in tumors. Nucl. Med. Biol. 26: 371–376
Altmann, A., and Haberkorn, U. 2003. Assessment of gene transfer using imaging methodology. Curr. Genom. 4: 167–184
Altmann, A., Kissel, M., Zitzmann, S., Kübler W, Mahmut M, Peschke P, and Haberkorn, U. 2003. Increased MIBG uptake after transfer of the human norepinephrine transporter gene in rat hepatoma. J. Nucl. Med. 44: 973–980
Altmann, A., Eisenhut, M., Mier, W., Karlsson, A., and Haberkorn, U. 2004. The Drosophila melanogaster deoxyribonucleoside kinase gene induces enhanced gemcitabine sensitivity in rat hepatoma cells. Eur. J. Nucl. Med. 31(2): S 357
Bahn, M.M., Huang, S.C., Hawkins, R.A., Satyamurthy, N., Hoffman, J.M., Barrio, J.R., Mazziotta, J.C. and Phelps, M.E. 1989. Models for in vivo kinetic interactions of dopoamine D2 neu-roreceptors and 3-(2′-[18F]Fluoroethyl)spirone examined by positron emission tomography. J. Cerebral. Blood Flow Metab. 9: 840–849
Barba, D., Hardin, J., Sadelain, M., and Gage, F.H. 1994. Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors. Proc. Natl. Acad. Sci. USA 91: 4348–4352
Barrio, J.R., Satymurthy, N., Huang, S.C., Keen, R.E., Nissenson, C.H., Hoffman, J.M., Ackermann, R.F., Bahn, M.M., Mazziotta, J.C. and Phelps, M.E. 1989. 3-(2′-[18F]Fluoroethyl)spirone: in vivo biochemical and kinetic characterization in rodents, nonhuman primates, and humans. J. Cerebral. Blood Flow Metab. 9: 830–839
Bell, J.D., and Taylor-Robinson, S.D. 2000. Assessing gene expression in vivo: magnetic resonance imagung and spectroscopy. Gene Ther. 7: 1259–1264
Benedetti, S., Bruzzone, M.G., Pollo, B., DiMeco, F., Magrassi, L., Pirola, B., Cirenei, N., Colombo, M.P., and Finocchiaro, G. 1999. Eradication of rat malignant gliomas by retroviral-mediated, in vivo delivery of the interleukin 4 gene. Cancer Res. 59: 645–652
Benedetti, S., Pirola, B., Pollo, B., Magrassi, L., Bruzzone, M.G., Rigamonti, D., Galli, R., Selleri, S., Di-Meco, F., De-Fraja, C., Vescovi, A., Cattaneo, E., and Finocchiaro, G. 2000. Gene therapy of experimental brain tumors using neural progenitor cells. Nat. Med. 6: 447–450
Bouali-Benazzouz, R., Laine, M., Vicat, J.M., Boisseau, S., Remy, C., Fouilhe, N., Thomas, F., Nissou, M.F., Benabid, A.L., and Berger, F. 1999. Therapeutic efficacy of the thymidine kinase/ganciclovir system on large experimental gliomas: a nuclear magnetic resonance imaging study. Gene Ther. 6: 1030–1037
Boyd, M., Cunningham, S.H., Brown, M.M., Mairs, R.J., Wheldon, T.E. 1999. Noradrenaline transporter gene transfer for radiation cell kill by 131I meta-iodobenzylguanidine. Gene Ther. 6: 1147–1152
Cho, J.Y., Xing S, Liu X, Buckwalter TL, Hwa L, Sferra TJ, Chiu IM, Jhiang SM. 2000. Expression and activity of human Na+/I− symporter in human glioma cells by adenovirus-mediated gene delivery. Gene Ther. 7: 740–749
Culver, K.W., Ram, Z., Walbridge, S., Ishii, H., Oldfiled, E.H., and Blaese, R.M. 1992. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256: 1550–1552
Deliganis, A.V., Baxter, A.B., Berger, M.S., Marcus, S.G., and Maravilla, K.R. 1997. Serial MR in gene therapy for recurrent glioblastoma: initial experience and work in progress. Am. J. Neuroradiol. 18: 1401–1406
De Vries, E.F., van Waarde, A., Harmsen, M.C., Mulder, N.H., Vaalburg, W., and Hospers, G.A. 2000. [11C]FMAU and [18F]FHPG as PET tracers for herpes simplex virus thymidine kinase enzyme activity and human cytomegalovirus infections. Nucl. Med. Biol. 27: 113–119
DiMeco, F., Rhines, L.D., Hanes, J., Tyler, B.M., Brat, D., Torchiana, E., Guarnieri, M., Colombo, M.P., Pardoll, D.M., Finocchiaro, G., Brem, H., and Olivi, A. 2000. Paracrine delivery of IL-12 against intracranial 9 L gliosarcoma in rats. J. Neurosurg. 92: 419–427
Gambhir, S.S., Barrio, J.R., Phelps, M.E., Iyer, M., Namavari, M., Herschmann, H.R. 1999. Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography. Proc. Natl. Acad. Sci. USA 96: 2333–2338
Gambhir, S.S., Bauer, E., Black, M.E., Liang Q., Kokoris M.S., Barrio, J.R., Iyer M., Namavari, M., Phelps M., and Herschmann H.R. 2000. A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography. Proc. Natl. Acad. Sci. USA 97: 2785–2790
Gati, W.P., Misra H.K., Knaus E.E., and Wiebe L.E. 1984. Structural modifications at the 2′ and 3′ positions of some pyrimidine nucleosides as determinants of their interaction with the mouse erythrocyte nucleoside transporter. Biochem. Pharmacol. 33: 3325–3331
Germann, C., Shields, A.F., Grierson, J.R., Morr, I., Haberkorn, U. 1998. 5-Fluoro-1-(2′-deoxy-2′-fluoro-ß-D-ribofuranosyl)uracil trapping in Morris hepatoma cells expressing the Herpes Simplex Virus thymidine kinase gene. J. Nucl. Med. 39: 1418–1423
Gerolami, R., Cardoso, J., Lewin, M., Bralet, M.P., Sa-Cunha, A., Clement,O., Brechot, C., and Tran, P.L. 2000. Evaluation of HSV-tk gene therapy in a rat model of chemically induced hepatocellular carcinoma by intratumoral and intrahepatic artery routes. Cancer Res. 60: 993–1001
Goodman, J.C., Trask, T.W., Chen, S.H., Woo, S.L., Grossman, R.G., Carey, K.D., Hubbard, G.B., Carrier, D.A., Rajagopalan, S., Aguilar-Cordova, E., and Shine, H.D. 1996. Adenoviral-mediated thymidine kinase gene transfer into the primate brain followed by systemic ganciclovir: pathologic, radiologic, and molecular studies. Hum. Gene Ther. 7: 1241–1250
Haberkorn, U. 1999. Monitoring of gene transfer for cancer therapy with radioactive isotopes. Ann. Nucl. Med. 13: 369–377
Haberkorn, U., and Altmann, A. 2001. Imaging methods in gene therapy of cancer. Curr. Gene Ther. 1: 163–182
Haberkorn, U., Strauss, L.G., Dimitrakopoulou, A., Seiffert, E., Oberdorfer, F., Ziegler, S., Reißer, C., Doll, J., Helus, F., and Kaick G. van 1993. Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy. J. Nucl. Med. 34: 12–17
Haberkorn, U., Oberdorfer, F., Klenner, T., Strauss, L.G., Stöhr, M., Wallich, R., Altmann, A., and Kaick, G. van 1994a. Metabolic and transcrip-tional changes in osteosarcoma cells treated with chemotherapeutic drugs. Nucl. Med. Biol. 21: 835–845
Haberkorn, U., Morr, I., Oberdorfer, F., Bellemann, M.E., Blatter, J., Altmann, A., Kahn, B., and Kaick, G. van 1994b. Fluorodeoxyglucose uptake in vitro: aspects of method and effects of treatment with gemcitabine. J. Nucl. Med. 35: 1842–1850
Haberkorn, U., Oberdorfer, F., Gebert, J., Morr I., Haack K., Weber K., Lindauer M., Kaick G. van, and Schackert H.K. 1996. Monitoring of gene therapy with cytosine deaminase: in vitro studies using 3H-5-fluorocytosine. J. Nucl. Med. 37: 87–94
Haberkorn, U., Bellemann, M.E., Altmann, A., Gerlach, L., Morr, I., Oberdorfer, F., Brix, G., Doll, J., Blatter, J., and Kaick, G. van 1997a. F-18-fluoro-2-deoxyglucose uptake in rat prostate adenocarcinoma during chemotherapy with 2′,2′-difluoro-2′-deoxycytidine. J. Nucl. Med. 38: 1215–1221
Haberkorn, U., Altmann, A., Morr, I., Germann, C., Oberdorfer, F., and Kaick, G. van 1997b. Multi tracer studies during gene therapy of hepatoma cells with HSV thymidine kinase and ganciclovir. J. Nucl. Med. 38: 1048–1054
Haberkorn, U., Altmann, A., Morr, I., Knopf, K.W., Germann, C., Haeckel, R., Oberdorfer, F., and Kaick, G. van 1997c. Gene therapy with Herpes Simplex Virus thymidine kinase in hepatoma cells: uptake of specific substrates. J. Nucl. Med. 38: 287–294
Haberkorn, U., Bellemann, M.E., Gerlach, L., Morr, I., Trojan, H., Brix, G., Altmann, A., Doll, J., and Kaick, G. van 1998a. Uncoupling of 2-fluoro-2-deoxyglucose transport and phosphor-ylation in rat hepatoma during gene therapy with HSV thymidine kinase. Gene Ther. 5: 880–887
Haberkorn, U., Khazaie, K., Morr, I., Altmann, A., Müller, M., and Kaick, G. van 1998b. Ganciclovir uptake in human mammary carcinoma cells expressing Herpes Simplex Virus thymidine kinase. Nucl. Med. Biol. 25: 367–373
Haberkorn, U., Henze, M., Altmann, A., Jiang, S., Morr, I., Mahmut, M., Peschke, P., Kübler W., Debus J., and Eisenhut M. 2001. Transfer of the human sodium iodide symporter gene enhances iodide uptake in hepatoma cells. J. Nucl. Med. 42: 317–325
Haberkorn, U., Altmann, A., and Eisenhut, M. 2002. Functional genomics and proteomics — the role of nuclear medicine. Eur. J. Nuc. Med. 29: 115–132
Haberkorn, U., Kinscherf, R., Kissel, M., Kübler W., Mahmut, M., Sieger, S., Eisenhut M, Peschke P, and Altmann A. 2003. Enhanced iodide transport after transfer of the human sodium iodide symporter gene is associated with lack of retention and low absorbed dose. Gene Ther. 10: 774–780
Hamstra, D.A., Rice, D.J., Pu, A., Oyedijo, D., Ross, B.D., and Rehemtulla, A. 1999. Enzyme/ prodrug therapy for head and neck cancer using a catalytically superior cytosine deaminase. Hum. Gene. Ther. 10: 1993–2003
Haubner, R. Avril, N., Hanzopoulos, P.A., Gansbacher, B., and Schwaiger, M. 2000. In vivo imaging of herpes simplex virus type 1 thymidine kinase gene expression: early kinetics of radiola-belled FIAU. Eur. J. Nuc. Med. 27: 283–291
Hospers, G.A., Calogero A., van Waarde A., Doze, P., Vaalburg, W., Mulder, N.H., and de Vries, E.F. 2000. Monitoring of herpes simplex virus thymidine kinase enzyme activity using positron emission tomography. Cancer Res. 60: 1488–1491
Huber, B.E., Austin, E.A., Good, S.S., Knick, V.C., Tibbels, S., and Richards, C.A. 1993. In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase. Cancer Res. 53: 4619–4626
Hüber, M.M. 1998. Fluorescently detectable magnetic resonance imaging agents. Bioconjug. Chem. 9: 242–249
Hustinx, R., Shiue, C.Y., Alavi, A., McDonald, D., Shiue, G.G., Zhuang, H., Lanuti, M., Lambright, E., Karp, J.S., and Eck, S. 2001. Imaging in vivo herpes simplex virus thymidine kinase gene transfer to tumour-bearing rodents using positron emission tomography and (18F)FHPG. Eur. J. Nucl. Med. 28: 5–12
Ichikawa, T., Tamiya, T., Adachi, Y., Ono, Y., Matsumoto, K., Furuta, T., Yoshida, Y., Hamada, H., and Ohmoto, T. 2000. In vivo efficacy and toxicity of 5-fluorocytosine/cytosine deaminase gene therapy for malignant gliomas mediated by adenovirus. Cancer Gene Ther. 7: 74–82
Lode, H.N., Bruchelt, G., Seitz, G., Gebhard, S., Gekeler, V., Niethammer, D., Beck, J. 1995. Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis of monoamine transporters in neuroblastoma cell lines: correlations to meta-iodobenzylguanidine (MIBG) uptake and tyro-sine hydroxylase gene expression. Eur. J. Cancer 31A: 586–590
MacLaren, D.C., Gambhir, S.S., Satyamurthy, N., Barrio, J.R., Sharfstein, S., Toyokuni, T., Wu, L., Berk, A.J., Cherry, S.R., Phelps, M.E., and Herschman, H.R. 1999. Repetitive non-invasive imaging of the dopamine D2 receptor as a reporter gene in living animals. Gene Ther. 6: 785–791
Mahony, W.B., Domin, B.A., McConnel, R.T., and Zimmerman, T.P. 1988. Acyclovir transport into human erythrocytes. J. Biol. Chem. 263: 9285–9291
Mairs, R.J., Livingstone, A., Gaze, M.N., Wheldon, T.E., Barrett, A. 1994. A Prediction of accumulation of 131I-labelled meta-iodobenzylguanidine in neuroblastoma cell lines by means of reverse transcription and polymerase chain reaction. Br. J. Cancer 70: 97–101
Maron, A., Gustin, T., Le-Roux, A., Mottet, I., Dedieu, J.F., Brion, J.P., Demeure, R., Perricaudet, M., and Octave, J.N. 1996. Gene therapy of rat C6 glioma using adenovirus-mediated transfer of the Herpes Simplex Virus thymidine kinase gene: long-term follow up by magnetic resonance imaging. Gene Ther. 3: 315–322
Morin, K.W., Knaus, E.E., Wiebe, L.I., Xia, H., and McEwan, A.J. 2000. Reporter gene imaging: effects of ganciclovir treatment on nucleoside uptake, hypoxia and perfusion in a murine gene therapy tumour model that expresses herpes simplex type-1 thymidine kinase. Nucl. Med. Commun. 21: 129–137
Mullen, C.A., Coale, M.M., Lowe, R., and Blaese, R.M. 1994. Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild type tumor. Cancer Res. 54: 1503–1506
Myers, C.E. 1981. The pharmacology of the fluor-opyrimidines. Pharmacological Reviews 33: 1–15
Namba, H., Tagawa, M., Miyagawa, T., Iwadate, Y., and Sakiyama, S. 2000. Treatment of rat experimental brain tumors by herpes simplex virus thymidine kinase gene-transduced allogeneic tumor cells and ganciclovir. Cancer Gene Ther. 7: 947–953
Namba, H., Tagawa, M., Miyagawa, T., Iwadate, Y., and Sakiyama, S. 2000. Treatment of rat experimental brain tumors by herpes simplex virus thy-midine kinase gene-transduced allogeneic tumor cells and ganciclovir. Cancer Gene Therap. 7: 947–953
Nishiyama, T., Kawamura, Y., Kawamoto, K., Matsumura, H., Yamamoto, N., Ito, T., Ohyama, A., Katsuragi, T., and Sakai, T. 1985. Antineoplastic effects of 5-fluorocytosine in combination with cytosine deaminase capsules. Cancer Res. 45: 1753–1761
Oliver, F.J., Collins, M.K.L., and Lopez-Rivas, A. 1997. Overexpression of a heterologous thymi-dine kinase delays apoptosis induced by factor deprivation and inhibitors of deoxynucleotide metabolism. J. Biol. Chem. 272: 10624–10630
Poptani, H., Puumalainen, A.M., Grohn, O.H., Loimas, S., Kainulainen, R., Yla-Herttuala, S., and Kauppinen, R.A. 1998. Monitoring thymi-dine kinase and ganciclovir-induced changes in rat malignant glioma in vivo by nuclear magnetic resonance imaging. Cancer Gene Ther. 5: 101–109
Ram, Z., Culver, W.K., Walbridge, S., Blaese, R.M., and Oldfield E.H. 1993. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res. 53: 82–88
Ram, Z., Walbridge, S., Shawker, T., Culver, K.W., Blaese, R.M., and Oldfield, E.H. 1994. The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9 L gliomas in rats. J. Neurosurg. 81: 256–260
Ram, Z., Culver, K., Oshiro, E.M., Viola, J.J., DeVroom, H.L., Otto, E., Long, Z., Chiang, Y., McGarrity, G.J., Muul, L.M., Katz, D., Blaese, R.M., and Oldfield, E.H. (1997) Therapy of malignant brain tumors by intratumoral implan-tation of retroviral vector-producing cells. Nature Med. 3: 1354–1361
Rogers, B.E., McLean, S.F., Kirkman, R.L., Della Manna, D., Bright, S.J., Olsen, C.C., Myracle, A.D., Mayo, M.S., Curiel, D.T., and Buchsbaum, D.J. 1999. In vivo localization of [(111)In]-DTPA-D-Phe1-octreotide to human ovarian tumor xenografts induced to express the soma-tostatin receptor subtype 2 using an adenoviral vector. Clin. Cancer Res. 5: 383–393
Ross, B.D., Kim, B., and Davidson, B.L. 1995. Assessment of ganciclovir toxicity to experimental intracranial gliomas following recombinant adenoviral-mediated transfer of the herpes simplex virus thymidine kinase gene by magnetic resonance imaging and proton magnetic resonance spectroscopy. Clin. Cancer Res. 1: 651–657
Saito, Y., Price, R., Rottenberg, D.A., Fox, J.J., Su, T.L., Watanabe, K.A., and Philipps, F.A. 1982. Quantitative autoradiographic mapping of herpes simplex virus encephalitis with radiolabeled antiviral drug. Science 217: 1151–1153
Sandmair, A.M., Loimas, S., Poptani, H., Vainio, P., Vanninen, R., Turunen,M., Tyynela, K., Vapalahti, M., and Yla-Herttuala, S. 1999. Low efficacy of gene therapy for rat BT4C malignant glioma using intra-tumoural transduction with thymidine kinase retrovirus packaging cell injections and ganciclovir treatment. Acta Neurochir. Wien 141: 867–872
Sieger, S., Jiang, S., Schönsiegel, F., Eskerski H., Kübler W., Altmann A., and Haberkorn U. 2003. Tumour specific activation of the Sodium/Iodide Symporter Gene under Control of the Glucose Transporter Gene 1 Promoter (GTI-1.3). Eur. J. Nucl. Med. 30: 748–756
Shand, N., Weber, F., Mariani, L., Bernstein, M., Gianella-Borradori, A., Long, Z., Sorensen, A.G., and Barbier, N. 1999. A phase 1–2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. GLI328 European-Canadian Study Group. Hum. Gene Ther. 10: 2325–2335
Shields, A.F., Lim, K., Grierson, J., and Krohn, K.A. 1990. Utilization of labelled thymidine in DNA sythesis : Studies for PET.J. Nucl. Med. 31: 337–342
Stegman, L.D., Rehemtulla, A., Beattie, B., Kievit, E., Lawrence, T.S., Blasberg, R.G., Tjuvajev, J.G., and Ross, B.D. 1999. Noninvasive quanti-tation of cytosine deaminase transgene expression in human tumor xenografts with in vivo magnetic resonance spectroscopy. Proc. Natl. Acad. Sci. USA 96: 9821–9826
Stegman, L.D., Rehemtulla, A., Hamstra, D.A., Rice, D.J., Jonas, S.J., Stout, K.L., Chenevert, T.L., and Ross, B.D. 2000. Diffusion MRI detects early events in the response of a glioma model to the yeast cytosine deaminase gene therapy strategy. Gene Ther. 7: 1005–1010
Su, M.Y., Taylor, J.A., Villarreal, L.P., and Nalcioglu, O. 2000. Prediction of gene therapy-induced tumor size changes by the vascularity changes measured using dynamic contrast-enhanced MRI. Magn. Reson. Imaging 18: 311–317
Tjuvajev, J.G., Avril, N., Oku, T., Sasayama, T., Miyagawa, T., Joshi, R., Safer, M., Beattie, B., DiResta, G., Daghighian, F., Augensen, F., Koutcher, J., Zweit, J., Humm J, Larson SM, Finn R, Blasberg R. 1998. Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography. Cancer Res. 58: 4333–4341
Venkataraman, G.M., Yatin, M., Marcinek, R., and Ain, K.B. 1999. Restoration of iodide uptake in dedifferentiated thyroid carcinoma: relationchip to human Na+/I−symporter gene methylation status. J. Clin. Endocrinol. Metab. 84: 2449–2457
Wallace, P.M., MacMaster, J.F., Smith, V.F., Kerr, D.E., Senter, P.D., and Cosand, W.L. 1994. Intratumoral generation of 5-fluorouracil mediated by an antibody-cytosine deaminase conjugate in combination with 5-fluorocytosine. Cancer Res. 54: 2719–2723
Weissleder, R., Simonova, M., Bogdanova, A., Bredow, S., Enochs, W.S., and Bogdanov, A. Jr. 1997. MR imaging and scintigraphy of gene expression through melanin induction. Radiology 204: 425–429
Weissleder, R., Tung, C.H., Mahmood, U., and Bogdanov, A. Jr. 1999. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nature Biotechnol. 17: 375–378
Weissleder, R., Moore, A., Mahmood, U., Bhorade, R., Benveniste, H., Chiocca, E.A., and Basilion, J.P. 2000. In vivo magnetic resonance imaging of transgene expression. Nature Med. 6: 351–354
Wertheimer, E., Sasson, S., Cerasi, E., and Ben-Neriah, Y. 1991. The ubiquitous glucose transporter GLUT-1 belongs to the glucose-regulated protein family of stress-inducible proteins. Proc. Natl. Acad. Sci. USA 88: 2525–2529
Zinn, K.R., Buchsbaum, D.J., Chaudhuri, T.R., Mountz, J.M., Grizzle, W.E., and Rogers, B.E. 2000. Noninvasive monitoring of gene transfer using a reporter receptor imaged with a high-affinity peptide radiolabeled with 99mTc or 188Re. J. Nucl. Med. 41: 887–895
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science + Business Media B.V
About this chapter
Cite this chapter
Altmann, A., Haberkorn, U. (2008). Assessment of Gene Transfer: Magnetic Resonance Imaging and Nuclear Medicine Techniques. In: Hayat, M.A. (eds) General Methods and Overviews, Lung Carcinoma and Prostate Carcinoma. Methods of Cancer Diagnosis, Therapy, and Prognosis, vol 2. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-8442-3_4
Download citation
DOI: https://doi.org/10.1007/978-1-4020-8442-3_4
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-8441-6
Online ISBN: 978-1-4020-8442-3
eBook Packages: MedicineMedicine (R0)